SCINAI IMMUNOTHERAPEUTICS LTD. Contributions To Plan Net Defined Benefit Liability Asset
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Contributions To Plan Net Defined Benefit Liability Asset of ILS 314.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-28.
Discontinued › Notes
ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset · last filed 2022-03-28
ILS
| Period end | Contributions To Plan Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2021-12-31 | 314.00K ILS 20-F · filed 2022-03-28 |
| 2020-12-31 | 335.00K ILS 20-F · filed 2022-03-28 |
| 2019-12-31 | 332.00K ILS 20-F · filed 2022-03-28 |
| 2018-12-31 | 242.00K ILS 20-F · filed 2021-05-13 |
| 2017-12-31 | 196.00K ILS 20-F · filed 2020-06-12 |
| 2016-12-31 | 204.00K ILS 20-F · filed 2019-04-30 |
| 2015-12-31 | 198.00K ILS 20-F · filed 2018-04-30 |
USD
| Period end | Contributions To Plan Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2021-12-31 | $101.00K 20-F · filed 2022-03-28 |
| 2020-12-31 | $104.00K 20-F · filed 2021-05-13 |
| 2017-12-31 | $57.00K 20-F · filed 2018-04-30 |